CHARLOTTE, NC, July 08, 2022 /24-7PressRelease/ An estimated 30 million Americans suffer from osteoarthritis. Osteoarthritis or degenerative arthritis is the most common type of arthritis. Its a painful, often debilitating, a condition caused when the cartilage or cushion between our joints breaks down, leaving bone to rub on bone. Osteoarthritis is a leading cause of hospitalization, resulting in over 600,000 joint replacement surgeries annually.

Baby boomers want to stay active, but there is an added factor to developing osteoarthritis from prior injuries. You have an increased risk of developing arthritis from injuries, such as a cartilage tear in the knee, even minor ones, in your 20s or 30s.

Once osteoarthritis sets in, common treatments include over-the-counter pain relievers, prescription medications, physical therapy, or chiropractic adjustmentsnone help improve the joints quality. When the pain gets too great, the last option is joint replacement.

For years, orthopedic surgeons have used regenerative medicine, such as Platelet-Rich Plasma (PRP), to help patients recover faster. As the field of regenerative medicine has grown, experienced physicians are emerging.

Dr. James Altizer, MD, is a board-certified medical doctor who has performed thousands of stem cell and PRP procedures since January 2016, making him the most experienced doctor in the Carolinas.

Osteoarthritis and Regenerative Medicine Treatment

Typically, traditional osteoarthritis treatment aims to control the symptoms and cover up the pain until its too late to save the joint. Dr. Altizer treats underlying arthritis by stimulating the bodys natural healing process using regenerative medicine.

Regenerative medicine deals with the process of replacing or regenerating human cells or tissues to restore normal function naturally. This new therapeutic strategy helps prevent osteoarthritis from advancing by stimulating tissue regeneration in the joints and reducing inflammation, which leads to a significant reduction in pain and improved physical activity levels.

At Neogenix, a leading regenerative medicine provider, we treat the patient, not just the pain. Our team provides a personalized treatment plan to improve the lives of those suffering from osteoarthritis using natural regenerative therapies. The first step is where we get to know the patient and give a thorough assessment to determine the root cause of their pain.

We are at a tipping point in medicine when it comes to using our bodies to heal ourselves, says Dr. Altizer. Our patients see a significant reduction in their arthritis pain level and improvement in overall function, which can prolong their active lifestyle for many years.

If you are suffering from arthritis pain and want to put off future joint replacement surgery, schedule a consultation with Dr. Altizer. Find out now if regenerative medicine can help repair tissue damage in your joints.

ABOUT NEOGENIXNeogenix has been a leading regenerative medicine provider in the Carolinas since 2020. Dr. James Altizer, MD, is a board-certified medical doctor who has performed thousands of stem cell and growth factor procedures since January 2016, making him the most experienced doctor in the Carolinas. These powerful, all-natural treatments regenerate and heal damaged tissues to get you back to living the life you deserve. They offer realistic assessments, not false hope or high-pressure sales tactics. Patients experience little to no downtime, and these all-natural, non-surgical treatments carry none of the potentially life-threatening risks of surgery.

Press release service and press release distribution provided by http://www.24-7pressrelease.com

Follow this link:
Regenerative Medicine is an Early Treatment for Osteoarthritis - Digital Journal

Privately-held UK-based company Mogrify and Japanese drugmaker Astellas (TYO: 4503) have signed a collaborative research agreement on in vivo regenerative medicine approaches to address sensorineural hearing loss.

Using Mogrifys proprietary direct cellular reprogramming platform, the collaboration will seek to identify novel combinations of transcription factors involved in cell differentiation to generate new cochlear hair cells.

As part of the

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user pleaselogin. If your trial has come to an end, you cansubscribe here.

Try before you buy

All the news that moves the needle in pharma and biotech. Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters. Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech. Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results. Daily roundup of key events in pharma and biotech. Monthly in-depth briefings on Boardroom appointments and M&A news. Choose from a cost-effective annual package or a flexible monthly subscription.

Read more here:
Mogrify and Astellas link up on regenerative medicine approaches in sensorineural hearing loss - The Pharma Letter

Dublin, July 06, 2022 (GLOBE NEWSWIRE) -- The "Stem Cell Assays Market by Type (Viability, Proliferation, Differentiation, Apoptosis), Cell Type (Mesenchymal, iPSCs, HSCs, hESCs), Product & Service (Instrument), Application (Regenerative Medicine, Clinical Research), End User - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

The stem cell assay market is projected to reach USD 4.5 Billion by 2027 from USD 1.9 Billion in 2022, at a CAGR of 17.7% during the forecast period.

The growth of the market is projected to be driven by collaborations and agreements among market players for stem cell assay products & services, the launch of new stem cell analysis systems such as flow cytometers, and increase in R&D expenditure by biopharmaceutical and biotechnology companies.The viability/cytotoxicity assays accounted for the largest share of the type segment in the stem cell assays market in 2021Cell viability assays help to determine the number of live and dead cells in a culture medium. The viability/cytotoxicity assays include various types such as tetrazolium reduction assays, resazurin cell viability assays, calcein-AM cell viability assays, and other viability/cytotoxicity assays. The cell viability/cytotoxicity market is likely to be driven by rising R&D spending on stem cell research, an increase in demand for stem cell assays in drug discovery, and development of new stem cell therapies..The adult stem cells segment accounted for the largest share of the cell type segment in the stem cell assays market in 2021.Adult stem cells account for the largest share of the stem cell assay market. The adult stem cells include mesenchymal stem cells, induced pluripotent stem cells, hematopoietic stem cells, umbilical cord stem cells, and neural stem cells. The growth of the adult stems cells segment is driven by the increasing usage of adult stem cells in regenerative medicine and the development of advanced therapies.Asia Pacific: The fastest-growing region in the stem cell assays marketThe Asia Pacific is estimated to be the fastest-growing segment of the market, owing to the rising prevalence of cancer & other diseases, increasing R&D spending on biopharmaceutical projects, and focus on developing stem cell-based therapies. In this region, China and Japan are the largest markets.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights4.1 Stem Cell Assays Market Overview4.2 North America: Stem Cell Assays Market, by Product & Service and Country (2021)4.3 Stem Cell Assays Market Share, by Type, 2022 Vs. 20274.4 Stem Cell Assays Market Share, by Application, 20214.5 Stem Cell Assays Market: Geographic Growth Opportunities

5 Market Overview5.1 Introduction5.2 Market Dynamics5.2.1 Drivers5.2.1.1 Increasing Awareness About Therapeutic Potency of Stem Cells5.2.1.2 Increasing Funding for Stem Cell Research5.2.1.3 Rising Demand for Cell-Based Assays in Drug Discovery5.2.1.4 Collaborations and Agreements Among Market Players for Stem Cell Assay Products & Services5.2.1.5 Rising Incidence of Cancer5.2.2 Restraints5.2.2.1 Issues in Embryonic Stem Cell Research5.2.2.2 High Cost of Stem Cell Analysis Instruments5.2.3 Opportunities5.2.3.1 Emerging Economies5.2.3.2 Government Initiatives to Boost Stem Cell Research5.2.4 Challenges5.2.4.1 Lack of Infrastructure for Stem Cell Research in Emerging Economies5.2.4.2 Dearth of Trained and Skilled Professionals5.3 Ranges/Scenarios5.4 Impact of COVID-19 on Stem Cell Assays Market5.5 Trends/Disruptions Impacting Customers' Business5.6 Pricing Analysis5.6.1 Average Selling Prices of Products Offered by Key Players5.6.2 Average Selling Price Trend5.7 Technology Analysis

6 Stem Cell Assays Market, by Type6.1 Introduction6.2 Viability/Cytotoxicity Assays6.3 Isolation & Purification Assays6.4 Cell Identification Assays6.5 Proliferation Assays6.6 Differentiation Assays6.7 Function Assays6.8 Apoptosis Assays

7 Stem Cell Assays Market, by Cell Type7.1 Introduction7.2 Adult Stem Cells7.3 Human Embryonic Stem Cells

8 Stem Cell Assays Market, by Product & Service8.1 Introduction8.2 Instruments8.3 Kits8.4 Services

9 Stem Cell Assays Market, by Application9.1 Introduction9.2 Regenerative Medicine & Therapy Development9.3 Drug Discovery & Development9.4 Clinical Research

10 Stem Cell Assays Market, by End-User

11 Stem Cell Assays Market, by Region

12 Competitive Landscape

13 Company Profiles

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/2i79h7

See the article here:
Global Stem Cell Assays Market Projected to Reach $4.5 Billion by 2027 - GlobeNewswire

The Global Orthopedic Regenerative Medicine Marketreport provides an in-depth analysis of emerging trends, market drivers, development opportunities and market constraints that may affect the industrys market dynamics. Each market sector is examined in depth in Reports Globe, including products, applications and competition analysis.

The report was created using three different recognition systems. The first step requires in-depth primary and secondary research on a wide range of topics. Approvals, ratings and results based on accurate data obtained by industry specialists are the next step. The research derives an overall estimate of the market size using top-down methods. Finally, the research evaluates the market for a series of sections and subsections using information triangulation and market separation techniques.

Key Drivers & Barriers:

High-impact factors and rendering engines have been studied in the Orthopedic Regenerative Medicine market report to help readers understand the overall development. In addition, the report contains restrictions and challenges that may stand in the way of players. This will help users pay attention and make informed business-related decisions. The specialists also looked at the next business outlook.

In its latest report, ReportsGlobe offers a comprehensive overview of the Orthopedic Regenerative Medicine market with an emphasis on keyword dynamics including driving forces, constraints, opportunities, trends and detailed information on Orthopedic Regenerative Medicine market structure. Orthopedic Regenerative Medicine s market sales in the global market will increase as activities and advanced technology increase. With the outbreak of covid-19, companies have become very dependent on digital platforms to survive.

Orthopedic Regenerative Medicine Market Segmentation:

Orthopedic Regenerative Medicine Market, By Treatment Type (2017-2028)

Orthopedic Regenerative Medicine Market, By Disease Indication (2017-2028)

Orthopedic Regenerative Medicine Market, By End User (2017-2028)

Major Players Operating in the Orthopedic Regenerative Medicine Market:

Orthopedic Regenerative Medicine Market Segment Analysis

The market research explores new data in the Orthopedic Regenerative Medicine market report. It examines the market size in terms of the value of each segment, as well as how market dynamics are likely to change over time. The report then divides this information into types and proposed applications, with a breakdown by geography (North America, Asia, Europe, and the Rest of the World). In addition, the report examines the structure of the industry, offers growth, forecast period, revenue value and volume estimates in industrial applications, and provides clarity regarding industry competition.

Orthopedic Regenerative Medicine Market Report Scope

ATTRIBUTES

Description

ESTIMATED YEAR

2022

BASE YEAR

2021

FORECAST YEAR

2022 to 2028

HISTORICAL YEAR

2020

SEGMENTS COVERED

Types, Applications, End-Users, and more.

REPORT COVERAGE

Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends

BY REGION

North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Regional Analysis of the Orthopedic Regenerative Medicine Market:

The Orthopedic Regenerative Medicine Market research report details the ongoing market trends, development outlines, and several research methodologies. It illustrates the key factors that directly manipulate the Market, for instance, production strategies, development platforms, and product portfolio. According to our researchers, even minor changes within the product profiles could result in huge disruptions to the above-mentioned factors.

Goals and objectives of the Orthopedic Regenerative Medicine Market Study

The study thoroughly examines the profiles of major market players and their major financial aspects. This comprehensive business analysis report is useful for all new and existing participants when designing their business strategies. This report covers Orthopedic Regenerative Medicine s market output, revenue, market shares and growth rates for each key company and covers breakdown data (production, consumption, revenue and market shares) by regions, type and applications. Orthopedic Regenerative Medicine historical breakdown data from 2017 to 2021 and forecast for 2022-2028.

Global Orthopedic Regenerative Medicine Market Research Report 2022 2028

Chapter 1 Orthopedic Regenerative Medicine Market Overview

Chapter 2 Global Economic Impact on Industry

Chapter 3 Global Market Competition by Manufacturers

Chapter 4 Global Production, Revenue (Value) by Region

Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions

Chapter 6 Global Production, Revenue (Value), Price Trend by Type

Chapter 7 Global Market Analysis by Application

Chapter 8 Manufacturing Cost Analysis

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders

Chapter 11 Market Effect Factors Analysis

Chapter 12 Global Orthopedic Regenerative Medicine Market Forecast

How Reports Globe is different than other Market Research Providers:

The inception of Reports Globe has been backed by providing clients with a holistic view of market conditions and future possibilities/opportunities to reap maximum profits out of their businesses and assist in decision making. Our team of in-house analysts and consultants works tirelessly to understand your needs and suggest the best possible solutions to fulfill your research requirements.

Our team at Reports Globe follows a rigorous process of data validation, which allows us to publish reports from publishers with minimum or no deviations. Reports Globe collects, segregates, and publishes more than 500 reports annually that cater to products and services across numerous domains.

Contact us:

Mr. Mark Willams

Account Manager

US: +1-970-672-0390

Email:sales@reportsglobe.com

Website:Reportsglobe.com

Read more from the original source:
Orthopedic Regenerative Medicine Market Global Industry Research Analysis & Forecast 2022 to 2028 | Ortho Regenerative Technologies Inc.,...

Wilmington, Delaware, United States, Transparency Market Research Inc.: The global cranial implants market is expanding due to an increase in the number of brain cancer and trauma cases and rapid technological advancements for establishing effective and efficient treatment platforms for cranial reconstruction. The global cranial implants market was valued at more than US$ 792.0 Mn in 2017. It is projected to reach a value of US$ 1.4 Bn by 2026, expanding at a CAGR of more than 6.5% from 2018 to 2026. The global market is expanding at a relatively higher growth rate due to an increase in the geriatric population, rise in the prevalence of cancer and trauma cases, increase in the number of cranial surgeries, research and developmental activities in the health care sector in both developed and developing countries

The human head can be subjected to several impactful loadings, such as those taking place due to falls, injuries, road accidents, etc.. These loadings may result in skull fracture, and in some cases, part of the skull may need to be replaced by a biomedical implant. Accidents may also lead to brain swelling, which can be treated by decompressive craniectomy.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=60159

Cranioplasty is a neurosurgical procedure that is used to repair cranial defects resulting due to traumatic brain injury (TBI), brain tumors, and hemorrhagic diseases. This procedure is conducted with the aid of cranial implants. Earlier, several different types of materials were used for cranioplasty. With technological advancements, new materials and technological interventions are available, providing specificity for the patient population according to the treatment and surgeon.

Increase in technological advancements, such as implant computer-aided design, 3-D printing, and regenerative medicine has resulted in the advent of 3-D-print patient-specific implants that can be made from a variety of materials, including polymer, ceramic, or metal. They are more effective and accurate for treatment and help surgeons achieve increased success rates. Also, factors such as a rise in the geriatric population, increase in demand for customized cranial implants, and rise in the number of injuries and road accidents are boosting the growth of the cranial implants market. Furthermore, an increase in research and development activities and studies and rise in awareness are also anticipated to boost the cranial implants market.

Request Sample of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=60159

The global cranial implants market has been segmented based on product, material, end-user, and region. In terms of product, the market has been classified into customized cranial implants and non-customized cranial implants. The non-customized cranial implants segment is expected to hold a significant share of the market, while the customized cranial implants segment is expected to expand at a significant CAGR of 7.1% during the forecast period. Customized cranial implants are considered to be specific and well-fitted according to the cranial defects, save operating room procedure time and aid surgeons, may render the procedure less invasive, and reduce the risk of infection and complications. Generally, non-customized implants comprise traditional methods for cranial implantation. The number of non-customized implant products available in the market is higher.

In terms of material, the global cranial implants market has been classified into polymer, ceramic, and metal. The metal segment is projected to hold a prominent share of the market, while the polymer segment is anticipated to expand at a significant CAGR during the forecast period. The metal segment is estimated to expand at a CAGR of 6.8% during the forecast period. The most commonly used metal is grade 5 surgical titanium (i.e., Ti-6Al-4V), usually referred to as titanium or Ti-6-4. Metal is used in the cranium for fixation devices (e.g., plates and screws), solid plates, or mesh, or in combination with other materials such as ceramic components or inert plastic. The availability and long-term success rates of metals such as titanium, specifically related to resistance to infections, have contributed to their leading position in the cranial implants market.

Get COVID-19 Analysis on Cranial Implants Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=60159

In terms of end-user, the global cranial implants market has been classified into hospitals and neurosurgery specialty centers. The hospitals segment is expected to dominate the market and expand at a CAGR of 6.9% during the forecast period. This is due to a rise in the number of hospitals, high surgery volume, and rise in the number of medical professionals.

Based on region, the global cranial implants market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the global market and account for a prominent share in the coming years. The market in North America is primarily driven by a rapid increase in the geriatric population; rise in the patient population; high prevalence of trauma, injuries, road accidents, and brain cancer cases; and increase in the acceptance of technologically advanced cranial implants.

Moreover, increase in awareness among people, rise in the number of players and products, and substantial focus on research and development are anticipated to fuel the global cranial implants market in North America during the forecast period. According to The American Association for the Surgery of Trauma (AAST), in the U.S., traumatic brain Injury (TBI) is the single largest cause of death from injury. The market in Asia Pacific is anticipated to expand at a rapid pace during the forecast period. The market in the region is estimated to be augmented by the presence of a large base of geriatric population, government initiatives in the health care field, expansion in research and development activities, and improving health care infrastructure.

Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=60159

Companies such as Zimmer Biomet, Stryker, Kelyniam Global Inc., accounted for a major share of the global market in 2017. Increase in the number of technological advancements, rise in approvals from government bodies, acquisitions and mergers, and research and development are the key factors strengthening the position of these players in the market. In October, 2018, OssDsign AB, a distributor and manufacturer of regenerative implants for facial and cranial reconstruction, received 510(k) clearance by the U.S. FDA for the marketing and sale of its latest product, OSSDSIGN Cranioplug. Its implant is used during neurosurgical procedures, and it is made from an osteoconductive calcium phosphate ceramic composition reinforced with a titanium mesh plate. In October 2018, Kelyniam Global Inc., , submitted its third 510(k) application to the FDA for expanding its line of custom implants. Companies are adopting the strategies of acquisitions and collaborations with parallel companies in order to improve and strengthen their presence in the global market.

More Trending Reports by Transparency Market Research

Retractable Needles Market: https://www.transparencymarketresearch.com/retractable-needles-market.html

Sensor Based Smart Catheters Market: https://www.transparencymarketresearch.com/sensor-based-smart-catheters-market.html

Hearing Aids Market Revenue: https://www.transparencymarketresearch.com/hearing-aid-market.html

Eye Care Surgical Devices Market: https://www.transparencymarketresearch.com/eye-care-surgical-devices-market.html

Smart Fertility Tracker Market: https://www.transparencymarketresearch.com/smart-fertility-tracker-market.html

Radiation Therapy Market: https://www.transparencymarketresearch.com/radiation-therapy-market.html

Vascular Graft Market: https://www.transparencymarketresearch.com/vascular-graft-market.html

Heart Valve Devices Market: https://www.transparencymarketresearch.com/heart-valve-devices-market.html

About Us

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and business consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit BhiseyTransparency Market Research Inc.CORPORATE HEADQUARTER DOWNTOWN,1000 N. West Street,Suite 1200, Wilmington, Delaware 19801 USATel: +1-518-618-1030USA Canada Toll Free: 866-552-3453Website: https://www.transparencymarketresearch.comBlog: https://tmrblog.comEmail: sales@transparencymarketresearch.com

Go here to see the original:
Cranial Implants Market: Increase in the Number of Brain Cancer and Trauma Cases to Drive the Market - BioSpace

| 08 July 2022 | By Michael Mezher 2793 Welcome to another installment of This Week at FDA, your weekly source for updates big and small on FDA, drug and medical device regulation, and what were reading from around the web. This week, we learned that FDA is looking to hire a media-savvy physician to direct its communication strategy. The agency also authorized state-licensed physicians to prescribe Pfizers COVID-19 antiviral drug. Plus, we read that FDA and the US Patent and Trademark Office (USPTO) are planning to work more closely to promote drug competition.After learning of two high-profile hires at FDA last week, we read that FDA is eyeing Vin Gupta, a pulmonologist and Chief Medical Officer at Amazon, who also appears as a medical analyst for NBC and MSNBC, to serve as the agencys principal medical adviser. According to Politico, Gupta would be tasked with steering the agencys communication strategy and acting as a public face on high-profile issues and trying to bolster trust in the agencys health recommendations.Senate Democrats are reportedly working to advance legislation that would enable Medicare to negotiate prescription drug prices, according to Reuters. The news outlet reports that all 50 Senate Democrats are in line on the proposal, and according to Politico, the proposal has been sent to the Senate Parliamentarian for review as part of a larger reconciliation package.To ease access to Pfizers COVID-19 antiviral drug Paxlovid (nirmatrelvir and ritonavir), FDA on Wednesday moved to allow state-licensed pharmacists under certain circumstances. Since Paxlovid must be taken within five days after symptoms begin, authorizing state-licensed pharmacists to prescribe Paxlovid could expand access to timely treatment for some patients who are eligible to receive this drug for the treatment of COVID-19, said Center for Drug Evaluation and Research Director Patrizia Cavazzoni. The same will not be true for Mercks Lagevrio (molnupiravir), Fierce Pharma reports. Were also reading this blog from USPTO Director Kathi Vidal and FDA Commissioner Robert Califf on the two agencies efforts to promote competition and lower drug prices for all Americans. The two agency heads said that more work is needed to ensure that the patent system is not used to unjustifiably delay generic drugs and biosimilar competition beyond that reasonably contemplated by law. The two said their agencies will work more closely with the aim of protecting against the patenting of incremental, obvious changes to existing drugs that do not qualify for patents.Drugs & biologicsThis week, we learned that FDA will reconvene its Peripheral and Central Nervous System Drugs Advisory Committee (PCNSDAC) to review Amylyx Pharmaceuticals amyotrophic lateral sclerosis (ALS) drug known as AMX0035 for a second time in September. The rare move comes after the agency extended its Prescription Drug User Fee Act (PDUFA) goal date for the drug. In March, the PCNSDAC voted 6-4 against approving the drug, Stat reported.The agency also granted Biogen and Eisais Alzheimers disease drug lecanemab priority review under the accelerated approval pathway, with a PDUFA goal date of 6 January 2023. The news follows the agencys controversial decision to grant accelerated approval to the pairs other Alzheimers drug Aduhelm (aducanumab) last June.We also saw FDAs Office of New Drugs (OND) release its 2021 annual report detailing its activities and accomplishments during the calendar year.FDA announced on Friday it is withdrawing Xellia Pharmaceuticals abbreviated new drug application for bacitracin for injection, 50,000 units/vial, at the companys request. The withdrawal comes after the agencys Antimicrobial Drugs Advisory Committee voted almost unanimously that the drugs risks outweigh its benefits for its sole approved indication in April 2019. The agency called for companies to voluntarily withdraw their applications for the drug in early 2020.FDA has released new quarterly data on its regenerative medicine advance therapy (RMAT) designation, which shows that the agency received 21 requests so far in FY2022, compared to a total of 24 requests in all of FY2021. The agency has already granted 9 of those requests, already exceeding the number granted in the previous year.Medical devicesFDA has identified Getinge USAs recall of its Flow-c and Flow-e anesthesia systems as a Class I recall due to the risk of cracked or broken suction system power switches, which could cause delays during procedures or between procedures, and could cause choking, inability of oxygen to get into the blood, pneumonia, brain injury or death. FDA said it has received 21 complaints related to the issue, though none that cited injury or death.Were also looking forward to FDAs upcoming Patient Engagement Advisory Committee meeting next Tuesday and Wednesday. The committee will be tasked with making recommendations related to augmented reality (AR) and virtual reality (VR) medical devices.

2022Regulatory Affairs Professionals Society.

Continued here:
This Week at FDA: USPTO, FDA align on drug competition, Paxlovid from your pharmacist, and more - Regulatory Focus

A new biomanufacturing method for constructing 3D scaffolds composed of narrow fibers with specific alignments has been developed. The method, called focused rotary jet spinning (FRJS), is enabling researchers to fabricate heart structures and to study how the helical alignments of fibers in the musculature of the heart enhance cardiac function.

The findings, which provide proof-of-concept for a streamlined approach to engineering tissues and organs with complex 3D geometries, were reported by Huibin Chang, PhD, a research associate in bioengineering at Harvard University, and colleagues in a Science article entitled Recreating the hearts helical structure-function relationship with focused rotary jet spinning.

The hearts pumping action comes from cardiomyocytesthe muscle cells of the heartwhich are organized as helical fibers that envelop the ventricles. With each beat, this arrangement results in a combined contracting and twisting motion.

However, it is difficult to specifically assess the extent to which the hearts helical structure contributes to its function, wrote Michael Sefton, ScD, and Craig Simmons, PhD, from the Institute of Biomedical Engineering at the University of Toronto, in a perspective that accompanied the research article. To that end, understanding and replicating the hearts helical structure-function relationship is thought to be an important step.

Designing scaffolds and materials that adequately recapitulate native heart function can be challenging. The newly reported FRJS method offers improvements in fabrication speed and complexity over conventional methods.

In FRJS, long, free-floating polymer fibers are expelled by centrifugal force, and air jet streams align and deposit the fibers on molds. By controlling the shape and rotation of the mold, scaffolds with specific fiber orientations can be constructed. The scaffolds can then be seeded with cellscardiomyocytes, in this caseto recapitulate tissue and organ structures.

Using their method, Chang and colleagues fabricated heart ventricles with similar structural properties to those in natural human hearts. They also fabricated models of diseased hearts with misaligned fiber orientations. Once the scaffolds were seeded with human cardiomyocytes, the authors showed that the helical architecture increased cardiac performance, illustrating that the helical tissue pattern plays a role in the pumping function of the heart.

But the heart is more than a pump. To achieve a fully functional bioengineered heart for use in regenerative medicine, an electrical conduction system, vasculature, and means to avoid immune responses are still needed.

The FRJS method provides an initial pathway toward fabricating more complex tissues and organs. In addition to biofabrication, FRJS may serve an important role in other additive manufacturing processes, wrote Chang and colleagues. It provides production rates comparable to those of current industrial processes while enabling micro/nanoscale feature sizes and controlled 3D alignments.

Original post:
New Biofabrication Process Developed to Engineer Heart Structures - Genetic Engineering & Biotechnology News

WINSTON-SALEM, N.C., July 5, 2022 /PRNewswire/ -- Plakous Therapeutics, Inc. today announced it is has received more than $300,000 in funding from the North Carolina Biotechnology Center (NCBiotech). The funding will support ongoing development and marketing of Protego-PD, the regenerative medicine company's first product.

Plakous received the funding through two NCBiotech programs. Plakous was named the winner of NCBiotech's BIONEER Venture Challenge. Throughout the months-long competition, the company received $60,000. Earlier last month, NCBiotech awarded Plakous a Small Business Research Loan of $250,000 after several months of rigorous due diligence.

"We are grateful to NCBiotech for its mentorship and confidence in our research and development," said Plakous CEO Robert Boyce. "Their loans and grants will complement our currently open $4M seed round to support efforts related to our upcoming Investigational New Drug filing for Protego-PD, our orally delivered acellular biotherapeutic for necrotizing enterocolitis (NEC)."

Plakous' success underscores the strong life sciences community in the state.

"It is exciting and encouraging when research and therapies advance toward commercialization," said Nancy Johnston, NCBiotech executive director for the Piedmont Triad office. "Not only does this attract additional investments, but it also demonstrates the diversity of discovery and solutions underway in the Piedmont Triad."

NEC is a devastating disease with a 30% mortality rate. NEC affects premature infants with very low birthweight (those born weighing less than three pounds) and is caused by inflammation and lack of development of the intestine. Managing NEC consumes 20% of NICU expenditures annually. Plakous seeks to prevent NEC by accelerating intestinal maturation of premature infants with Protego-PD.

About Plakous Therapeutics, Inc.

Plakous Therapeutics is a biotherapeutic company dedicated to researching and developing placenta derived regenerative therapies to improve patient outcomes and reduce health care costs. For more information, please visit the company's website at plakoustherapeutics.com.

SOURCE Plakous Therapeutics, Inc.

Read more here:
Plakous Therapeutics Announces New Funding to Support Development of Therapies for Necrotizing Enterocolitis - PR Newswire

The global 3D bioprinting market (henceforth referred to as the market studied) was valued at USD 586.13 million in 2019, and it is expected to reach USD 1949.94 million by 2025, registering a CAGR of 21.91%, during the period of 2022-2031. The global 3D bioprinting market is expected to experience growth, owing to its revolutionary breakthrough in healthcare and pharmaceutical industries.

3D bioprinting is an emerging field represented by various biologically applied deposition and assembling systems, which include direct writing, photolithography, microstamping, extrusion, laser writing, stereolithography, electro-printing, microfluidics, and inkjet deposition. Healthcare is one of the major markets where 3D bioprinting has been bringing a seismic change. This is majorly because of the increasing investments in healthcare applications, such as model and organ prototyping and production throughout the globe, and growing innovations in healthcare through 3D printing.

The primarily growing bioprinting applications include 3D bioprinted tissue and hair follicles, as they are very beneficial to cosmetics companies, especially in Europe, where animal testing for cosmetics was banned in 2013. For a cosmetic company, the advantage will be the ability to economically and ethically test products (i.e., not on animals) across varying skin types, for more accurate results.

Several companies have been undergoing extensive R&D expenditures to boost the market growth by making significant product developments and innovations. For instance, Organovo, a medical laboratory and research company, has been at the front of the R&D of 3D bioprinting in the country.

The market studied has been viewing strategic partnerships and collaborations as a lucrative path towards the expansion of the market presence, by leveraging the various skills and expertise of the other players in the market. For instance, in December 2019, CELLINK, a Swedish 3D bioprinter manufacturer collaborated with microgravity manufacturer, Made In Space., with the aim to identify 3D bioprinting development opportunities for the International Space Station (ISS).

Download PDF Sample Report For More [emailprotected] https://www.sdki.us/sample-request-90081

Key Market Trends

Drug Testing to Hold Major Share

3D bioprinters are of the highest importance for drug testing and clinical trial applications expected to drastically reduce the need for animal trials (therefore not only being ethically beneficial but also being cost-effective).

Traditionally, clinical trials for new drug development involved testing on animals with artificially induced affected tissues. With the advent of 3D bioprinting, drug developers may be able to address the complications associated with human clinical trials of new drugs, by identifying them in a short period (since these can be tested with human-like 3D printed tissues). Thus, they are expected to reduce the losses incurred during late-stage failures.

The regulatory agency of the United States Food and Drug Administration has already started to consider integrating alternatives for drug safety and efficacy assessment, providing scope for the market. Companies, like Organovo (US-based) were instrumental in the development of 3D bioprinter able to develop liver and kidney tissue for drug discovery applications.

In April 2019, NIBIB-funded researchers at the University of Minnesota (UMN) created a new, dynamic 3D Bioprinted tumor model in a laboratory dish to screen anticancer drugs and study the spread of cancer and primary site tumor growth.

Asia-Pacific Anticipated to Witness Fastest Growth

Asia-Pacific is the fastest-growing market for 3D bioprinting, mainly due to a strong existing consumer base that will drive demand for 3D bioprinting, huge scope of 3D printing in medical services, increasing R&D for 3D printing, and government support and tax incentives.

The Chinese researchers have made rapid advancements in 3D-bioprinting technology, such as Liquid-in-liquid printing method. This method involves liquid polymers that create a stable membrane where they meet. The resulting liquid structures, as they claim, can hold their shape for as long as 10 days, before they begin to merge. Using this new technique, they were able to print an assortment of complex shapes. This has further been leading the path to print complex 3D-printed tissues made, by including living cells.

The Japanese government estimates that the regenerative medicine industry is presumed to grow to JPY 1 trillion by 2030, the New Energy and Industrial Technology Development Organization (NEDO) expects that emerging and innovative technologies, such as 3D bioprinting, may lead the market in near future.

Access Free PDF Sample Report [emailprotected] https://www.sdki.us/sample-request-90081

In July 2019, the Government of India (GoI) also agreed to collaborate with the United States in the research and development of 3D bioprinting regenerative medicine. This co-operation involves the exchange of faculty members and students for the exchange of scientific ideas/information and technologies, as well as the joint use of scientific infrastructure for research, especially in the areas of 3D bioprinting.

The Government of South Korea announced plans to invest about USD 37 million to boost the development of 3D printing across the country. The countrys Ministry of Science announced plans to spend a considerable portion of its budget on a plethora of 3D applications, in order to strengthen its competitiveness and ability to meet the demand.

Competitive Landscape

The 3D bioprinting market is highly competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. These major players with a prominent share in the market have been focusing on expanding their customer base across foreign countries. These companies are leveraging strategic collaborative initiatives to increase their market share and increase their profitability.

In January 2020, 3D Systems and CollPlant Biotechnologies announced a joint development agreement to play a pivotal role in advancing and accelerating innovations in the biomedical industry. This alliance may be focusing on the development of regenerative medicines with the help of 3D bioprinting.

In September 2020, CELLINK launched its newly developed BIO X6, which is a six-printhead bioprinting system that allows the combination of various materials, tools, and cells. It also offers an intelligent exchangeable printhead system backed by CELLINKs patented Clean Chamber Technology. This product may help to enhance advanced research and clinical applications.

About Us

SDKI Incgoal is market scenarios in various countries such as Japan, China, the United States, Canada, the United Kingdom, and Germany. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. With SDKI gaining trust and a customer base in more than 30 countries, SDKI is even more focused on expanding its foothold in other pristine economies.

Contact Us

Lauren Brown

600 S Tyler StSuite 2100 #140AMARILLO, TX 79101Email:[emailprotected]

Follow this link:
3D Bioprinting Market Size In 2022 with CAGR of 21.91% : Industry Size Estimation, Revenue Analysis, Worldwide Research by Fastest Growing Companies -...

The Tissue Engineering market research report added by Report Ocean, is an in-depth analysis of the latest developments, market size, status, upcoming technologies, industry drivers, challenges, regulatory policies, with key company profiles and strategies of players. The research study provides market overview, Tissue Engineering market definition, regional market opportunity, sales and revenue by region, manufacturing cost analysis, Industrial Chain, market effect factors analysis, Tissue Engineering market size forecast, market data&Graphs and Statistics, Tables, Bar &Pie Charts, and many more for business intelligence.

Download Free Sample Copy of Tissue Engineering market Report @

https://reportocean.com/industry-verticals/sample-request?report_id=Pol1140

The global tissue engineering market size was US$ 12.1 billion in 2021. The global tissue engineering market is forecast to grow to US$ 39.4 billion by 2030 by registering a compound annual growth rate (CAGR) of 15.6% during the forecast period from 2022 to 2030.

Factors Influencing the Market

The global tissue engineering market is forecast to gain significant traction due to the rising demand for skin replacement surgeries. In addition, the demand for technologically advanced products is also growing at a rapid pace, which is expected to bring lucrative growth opportunities for the market during the study period.

The growing demand for inexpensive and readily available skin-replacement goods will also prompt market growth. In addition, rapidly rising cases of road accidents will also surge the demand for surgeries. Apart from that, growing healthcare expenditure, combined with the rising R&D activities in the region, will prompt the growth of the tissue engineering market.

Rapidly surging cases of chronic diseases and trauma injuries will drive the growth of the tissue engineering market during the forecast period. On the flip side, a lack of awareness about tissue engineering may limit the growth of the market during the study period.

COVID-19 Impact Analysis

Healthcare expenditure has significantly grown after the outbreak of the COVID-19 pandemic. The pandemic triggered the need to perform clinical research. However, the unavailability of raw materials hampered innovations in the tissue engineering industry. Apart from that, the focus of pharmaceutical and biotech companies has significantly inclined towards the development of drugs aimed at curing COVID-19 infection. As a result of delays & disruptions in clinical research and reduced demand for surgery, the market witnessed a notable drop in terms of revenue during the forecast period.

Regional Analysis

North America is forecast to dominate the tissue engineering market during the forecast period owing to the early adoption of advanced technology, rising healthcare expenditure, and efficient healthcare infrastructure. In addition to that, growing cases of chronic diseases and high awareness about the effectiveness of tissue engineering will contribute to this regional market growth. The market may also witness several opportunities due to the rising government financing and high healthcare spending.

Due to the escalating demand for advanced healthcare services in emerging nations, the regions increasing R&D industry, and the increased presence of important companies, Asia-Pacific offers attractive prospects for key players operating in the tissue engineering market. Additionally, the industry has developed in the past few years due to expanding healthcare infrastructure and an emphasis on regenerative medicine.

Key Segments Studied in the Global Tissue Engineering Market

Competitors in the Market

Market Segmentation

The global tissue engineering market segmentation focuses on Material, Application, and Region.

By Material Type

By Application

Impact of lockdowns, supply chain disruptions, demand destruction, and change in customer behavior

Optimistic, probable, and pessimistic scenarios for all markets as the impact of pandemic unfolds

Pre- as well as post-COVID-19 market estimates

Quarterly impact analysis and updates on market estimates

What is market research report?

Market research is a defined process to collect information about customers, competitors, and everything that a business needs to understand to sustain and grow. It offers important analysis to distinguish and examine the market needs, size, and trends. Market research is generally divided into, primary research and/or secondary research. The process usually includes collection and interpretation of market data by using statistical and analytical techniques to support the decision making process. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Market research reports provide in-depth analysis about the market conditions and requirements for effective decision making.

The report provides a snapshot of the global market size, segmentation data, marketing growth strategies, market share, export and import information, analysis and forecast of market trends, competition, domestic production, best sales prospects, statistical data, tariffs, regulations, distribution and business practices, end-user analysis, contact points and more. These research reports include information about competitive strategies, solutions, fact-based research, key takeaways, recommendations, market considerations, emerging business models and market opportunities for multiple segments of an industry. Market research reports assist in solving business problems and making better decisions to improve business as per the prevalent market trends.

What our reports offer:

Market share assessments for the regional and country-level segments

Strategic recommendations for the new entrants

Covers market data for 2020, 2021, till 2025

Market trends (drivers, opportunities, threats, challenges, investment opportunities, and recommendations)

Strategic recommendations in key business segments based on the market estimations

Competitive landscaping mapping the key common trends

Company profiling with detailed strategies, financials, and recent developments

Supply chain trends mapping the latest technological advancements

Browse market information, tables and figures extent in-depth TOC, The latest independent research document on various market development activities and business strategies such as new product/services development, Joint Ventures, partnerships, mergers and acquisitions, etc. In order to provide a more informed view, a market company profiles include Business Overview, Product / Service Offerings, SWOT Analysis, Segment & Total Revenue, Gross Margin and % Market Share. This report explores market definitions, overview, classification, segmentation, inclusive of market type and applications followed by product specifications, manufacturing initiatives, pricing structures, raw material sourcing and supply chain analysis.

Geographical Breakdown: Regional level analysis of the market, currently covering North America, Europe, China & Japan

(Check Our Exclusive Offer: Ask for Discount to our Representative)

https://reportocean.com/industry-verticals/sample-request?report_id=Pol1140

Changing Forecasts in a Time of Crisis: explores key issues, including:

Key questions answered: The Study Explore COVID 19 Outbreak Impact Analysis

Ask Our Expert for Complete Report@:

https://reportocean.com/industry-verticals/sample-request?report_id=Pol1140

Key Points Covered in Tissue Engineering Market Report:

Chapter 1, to describe Definition, Specifications and Classification of Global Tissue Engineering, Applications of, Market Segment by Regions;Chapter 2, to analyze the Manufacturing Cost Structure, Raw Material and Suppliers, Manufacturing Process, Industry Chain Structure;Chapter 3, to display the Technical Data and Manufacturing Plants Analysis of , Capacity and Commercial Production Date, Manufacturing Plants Distribution, Export & Import, R&D Status and Technology Source, Raw Materials Sources Analysis;Chapter 4, to show the Overall Market Analysis, Capacity Analysis (Company Segment), Sales Analysis (Company Segment), Sales Price Analysis (Company Segment);Chapter 5 and 6, to show the Regional Market Analysis that includes United States, EU, Japan, China, India & Southeast Asia, Segment Market Analysis (by Type);Chapter 7 and 8, to explore the Market Analysis by Application Major Manufacturers Analysis;Chapter 9, Market Trend Analysis, Regional Market Trend, Market Trend by Product Type, Market Trend by Application;Chapter 10, Regional Marketing Type Analysis, International Trade Type Analysis, Supply Chain Analysis;Chapter 11, to analyze the Consumers Analysis of Global Tissue Engineering by region, type and application;Chapter 12, to describe Tissue Engineering Research Findings and Conclusion, Appendix, methodology and data source;Chapter 13, 14 and 15, to describe Tissue Engineering sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source.

Continued.

..and view more in complete table of Contents

Browse Premium Research Report with Tables and Figures at @ https://reportocean.com/industry-verticals/sample-request?report_id=Pol1140

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

About Report Ocean:

We are the best market research reports provider in the industry. Report Ocean believe in providing the quality reports to clients to meet the top line and bottom line goals which will boost your market share in todays competitive environment. Report Ocean is one-stop solution for individuals, organizations, and industries that are looking for innovative market research reports.

Get in Touch with Us:

Report Ocean

Email: [emailprotected]

Address: 500 N Michigan Ave, Suite 600, Chicago, IIIinois 60611 UNITED STATES

Tel: +1 888 212 3539 (US TOLL FREE)

Website: https://www.reportocean.com/

Blog: https://reportoceanblog.com/

Read more:
Tissue Engineering Market Size Predicted to Increase at a Positive CAGR of 15.6% during the forecast period from 2022 to 2030 - Digital Journal